FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE EXTENDED-RELEASE — Supplemental Application (Vitruvias Therapeutics, Inc.)

View source ↗

Summary

FDA approved a supplemental application to allow marketing of an extended-release formulation of pramipexole dihydrochloride for conditions treated by pramipexo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease
• Restless Legs Syndrome

Drugs mentioned

• Pramipexole dihydrochloride extended-release (pramipexole dihydrochloride)

Snippet

SUPPL AP for PRAMIPEXOLE DIHYDROCHLORIDE EXTENDED-RELEASE (PRAMIPEXOLE DIHYDROCHLORIDE)